Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The president’s proposed Medicare Part D rule will restrict access to HIV meds. AIDS United wants him to withdraw it.
Plans have increasingly instituted preauthorization requirements for the opioid medication-assisted treatment buprenorphine.
A roundup of statements
Expand health care access; withdraw Medicare Part D changes.
More than 250,000 people living with HIV would be affected by a proposed rule change to Medicare Part D.
To quote the president: SAD!
The plan involves drugs available through Medicare.
The proposed rule would allow plans to exclude certain drugs in those protected classes, including antiretrovirals.
In a move to cut Medicare costs, the proposed changes would also affect people with cancer, depression and schizophrenia.
As the current number of Americans on PrEP hits an estimated 180,000, scant numbers of teenagers have ever taken Truvada as HIV prevention.
This is according to an analysis of hep C treatment rates at four large urban hospital systems.
Compared with their HIV-negative peers, HIV-positive individuals have higher rates of treatment for a host of health problems.
He’ll oversee the FDA, Medicare and Medicaid at a time when soaring drug prices remain a contentious political topic.
Cuts to the 340B program could lead to cutbacks—and even closings—at hospitals and HIV care providers.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.